Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases
Lindor, Keith D., Bowlus, Christopher L., Boyer, James, Levy, Cynthia, Mayo, Marlyn·2019·Hepatology
Cited by (924)
Items 501–600 of 924
- Classic Autoimmune Liver Disorders and Celiac HepatitisMuhammad Amir, Samir Parekh · 2021 · Clinical Liver Disease
- Trends in Primary Biliary Cholangitis: Prospective Cohort Study From the European Reference Network Registry (R‐LIVER)Alessio Gerussi, Eugenia Nofit, Davide Paolo Bernasconi, C. Kroll, F. Groß, Ida Schregel, Alberto Marini, Laura Cristoferi, Federica Malinverno, Mária Papp et al. · 2025 · United European Gastroenterology Journal
- Profile of Patients with Primary Biliary Cholangitis and Evaluation of Response to Ursodeoxycholic Acid in a Romanian Center—Retrospective StudyMatei Mandea, Speranta Maria Iacob, Mihaela Corina Ghioca, Cristian Gheorghe, Liliana Simona Gheorghe · 2025 · Journal of Clinical Medicine
- Advancing the Diagnosis and Management of Genetic Cholestatic Liver Disease in AdultsAhmad Basil Nasir, Naim Alkhouri, Robert Gareth Gish · 2025 · Digestive Diseases and Sciences
- Current and future opportunities for the management of primary biliary cholangitisSandra Naffouj, Jennifer Rui Wang · 2023 · Frontiers in Gastroenterology
- Risk factors for cancer in patients with primary biliary cholangitis and autoimmune hepatitis and primary biliary cholangitis overlap syndromeMichelle Harriz Braga, Guilherme Grossi Lopes Cançado, Paulo Lisboa Bittencourt, Cláudia Alves Couto, Laura Vilar Guedes, André Mourão Costa Lima, Maria Lúcia Gomes Ferraz, Cristiane Alves Villela‐Nogueira, Mateus Jorge Nardelli, Luciana Costa Faria et al. · 2023 · Annals of Hepatology
- Breaking Grounds: A Comprehensive Analysis of Cutting-Edge Treatments for Primary Biliary Cirrhosis/Primary Biliary Cholangitis With Futuristic TreatmentsAsad Ali Khan, Furqan Ul Haq, Qazi Muhammad Farooq Wahab, Taimur Aslam, Azeem Khalid, Asad Abu Bakar Ali · 2025 · Cureus
- Cross‐Phenotype Genome‐Wide Association Study on the Shared Genetic Susceptibility to Systemic Sclerosis and Primary Biliary CholangitisYiming Luo, Atlas Khan, Lili Liu, Cue Hyunkyu Lee, Gabriel J. Perreault, Sydney F. Pomenti, Pravitt Gourh, Krzysztof Kiryluk, Elana J. Bernstein · 2024 · Arthritis & Rheumatology
- Definition and validation of recompensation in patients with primary biliary cholangitis-related decompensated cirrhosis treated with ursodeoxycholic acid: Based on the BAVENO VII criteriaDawei Ding, Lina Cui, Gui Jia, Boling Wang, Linhua Zheng, Juan Deng, Ruiqing Sun, Xiufang Wang, Yulong Shang, Guanya Guo et al. · 2025 · Journal of Translational Internal Medicine
- Clinical significance of anti-mitochondrial antibodies and PBC-specific anti-nuclear antibodies in evaluating atypical primary biliary cholangitis with normal alkaline phosphatase levelsShasha Li, Kai Zhang, Hongli Liu, Miaoyang Chen, Jialuo Wang, Yuan Yang, Yuxiang Gong, Xing Liu, Yongfeng Yang · 2025 · Clinical Chemistry and Laboratory Medicine (CCLM)
- Noninvasive prediction of insufficient biochemical response after ursodeoxycholic acid treatment in patients with primary biliary cholangitis based on pretreatment nonenhanced MRIYun Zhang, Xiaoli Fan, Bin Song, Yifeng Liu, Yidi Chen, Tianying Zheng, Yuxin Guo, Ting Duan, Zixing Huang, Li Yang · 2023 · European Radiology
- Spanish clinical practice guidelines for the diagnosis and management of cholestatic liver diseases in adult and pediatric population: Joint report from AEEH and SEGHNPÁlvaro Díaz‐González, Cristina Molera, Elena Gómez Domínguez, Gema Muñoz‐Bartolo, Javier Ampuero, Conrado Fernández‐Rodríguez, Jesús Quintero, Esther Molina, Magdalena Salcedo, Antonio Olveira et al. · 2025 · Gastroenterología y Hepatología (English Edition)
- Gastric Antral Vascular Ectasia as the First Presentation of Primary Biliary CholangitisSugata Narayan Biswas, Anshuman Elhence, Vinita Agrawal · 2022 · Cureus
- Pruritus and health-related quality of life in chronic liver disease: a longitudinal, survey-based cohort studyUsha Gungabissoon, Jacob N. Hunnicutt, Eleanor McDermott, Andrew Lovley, Monica Frazer, Kaitlin LaGasse, Mark R. Kosinski, Kristen L. McCausland, Ashleigh A. McGirr, Helen T. Smith et al. · 2025 · BMJ Open Gastroenterology
- Impact of Alkaline Phosphatase Normalization on Complication-Free Survival in Primary Biliary CholangitisAnish Reddy, Adrielly Martins, Christopher L. Bowlus, Marlyn J. Mayo, Elizabeth J. Carey, Mark Wong, Michael Weiss, Hany A. Elbeshbeshy, Raymond A. Rubin, Velimir A. Luketic et al. · 2026 · The American Journal of Gastroenterology
- PSC and Overlap SyndromesNathalie A. Pena Polanco, Claudia Cottone, Kalyan Ram Bhamidimarri · 2020 · Current Hepatology Reports
- TR score: A noninvasive model to predict histological stages in patients with primary biliary cholangitisZhixin Tu, Yao Wang, Yan Wang, Jianjie Huang, Yujin Han, Qijia Ji, Xiaoxuan Cao, Xiaoyu Wen, Yang Wang, Qinglong Jin · 2023 · Frontiers in Immunology
- High biochemical remission rates in patients with primary biliary cholangitis treated with “triple” anticholestatic therapyGuilherme Grossi Lopes Cançado, Bo Chen, Madeline Cameron, Inbal Houri, Kristel K. Leung, Aliya F. Gulamhusein, Bettina E. Hansen, Gideon Morris Hirschfield · 2025 · Hepatology Communications
- Autoantibodies in Primary Biliary Cholangitis: From Classical Markers to Emerging TargetsShima Mimura, Asahiro Morishita, Kyoko Oura, Rie Yano, M. Nakahara, Tomoko Tadokoro, Koji Fujita, Joji Tani, Miwa Tatsuta, Takashi Himoto et al. · 2025 · Journal of Clinical Medicine
- Treatment of Primary Biliary Cholangitis including TransplantationYasameen Muzahim, Ali Wakil, Mehak Bassi, Nikolaos Pyrsopoulos · 2023 · Clinics in Liver Disease
- Increased risk of fragility fractures in patients with primary biliary cholangitisJihye Lim, Ye‐Jee Kim, Sehee Kim, Jonggi Choi · 2024 · JBMR Plus
- Diagnostic value of quantitative chemiluminescence immunoassay for anti-gp210 and anti-sp100 antibodies in primary biliary cholangitisYazhen Zhang, Yujiao Jin, Yuan Liu · 2024 · Clinical Chemistry and Laboratory Medicine (CCLM)
- Bile acid therapy for primary biliary cholangitis: Pathogenetic validationVasiliy Ivanovich Reshetnyak, Igor Veniaminovich Maev · 2024 · World Journal of Experimental Medicine
- Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary CholangitisKris V. Kowdley, Cynthia Levy, David Jones · 2024 · New England Journal of Medicine
- Inflammatory Demyelinating Pseudotumor With Liver Dysfunction: IgG4 Related Disease With Primary Biliary CholangitisNing Tang, Yingbin Jiao, Yan Wang · 2020 · The American Journal of the Medical Sciences
- Primary biliary cholangitis: assessment and management strategiesS Nadir Abbas, David E. Jones, Yiannis N. Kallis, Laura Maher, Imran Patanwala · 2021 · Gastrointestinal Nursing
- Quality of Life in Patients With Variant Syndromes of Autoimmune Liver Diseases—A Cross‐Sectional Multicentre StudyNatalie Uhlenbusch, Romée J.A.L.M. Snijders, Meike Mund, Maciej K. Janik, Piotr Milkiewicz, Bernd Löwe, Claudia Kroll, Joanna Raszeja‐Wyszomirska, Alessio Gerussi, Francesca Bolis et al. · 2026 · Liver International
- Association of CCR6 functional polymorphisms with Primary Biliary CholangitisMingming Zhang, Zhuye Qin, Yexi Huang, Wenyan Tian, You Li, Chan Wang, Weifeng Zhao, Yaping Dai, Xingjuan Shi, Merrill Eric Gershwin et al. · 2024 · Journal of Translational Autoimmunity
- Association between ursodeoxycholic acid use and COVID-19 in individuals with chronic liver disease: a nationwide case-control study in South KoreaSang Yi Moon, Minkook Son, Yeo Wool Kang, Myeongseok Koh, Jong Yoon Lee, Yang Hyun Baek · 2024 · Virology Journal
- Colangitis biliar primaria: experiencia de cinco años en el Hospital Clínico de la Universidad de ChileFelipe Ramírez, Alvaro M. Urzua, Juan Pablo Roblero, Máximo Cattaneo, Carmen Hurtado, Jaime Poníachik · 2022 · Revista médica de Chile
- A new and simple score to predict adequate and deep response to ursodeoxycholic acid in patients with primary biliary cholangitis: the ALP-A scoreGuilherme Grossi Lopes Cançado, Nathália Mota de Faria Gomes, Cláudia Alves Couto, Eduardo Luiz Rachid Cançado, Débora Raquel Benedita Terrabuio, Cristiane Alves Villela‐Nogueira, Michelle Harriz Braga, Mateus Jorge Nardelli, Luciana Costa Faria, Elze Maria Gomes Oliveira et al. · 2024 · European Journal of Gastroenterology & Hepatology
- Clinical outcomes and sick leave in relation to UDCA treatment in Swedish patients with primary biliary cholangitisIda Henriksson, Ruzan Udumyan, Emma Nilsson, Kristina Önnerhag, Fredrik Rorsman, Mårten Werner, Hanns–Ulrich Marschall, Staffan Wåhlin, Nils Nyhlin, SweHep · 2022 · Scandinavian Journal of Gastroenterology
- Approach to Abnormal Liver Biochemistries in the Primary Care SettingR. Rajesh, Aditya Sangameshwar, Yi Yuan Tan, Kevin Teh Kim Jun, Tat Yean Tham, Mark Chang Chuen Cheah · 2024 · Cureus
- Excellent outcome in patients with primary biliary cholangitis in Northwest Italy followed up for up to 30 yearsCristina Rigamonti, Carla De Benedittis, Sara Labanca, Ester Vanni, Anna Morgando, Giulia Francesca Manfredi, Danila Azzolina, Micol Giulia Cittone, Edoardo Giovanni Giannini, Giorgio Maria Saracco et al. · 2023 · European Journal of Gastroenterology & Hepatology
- CCL26 in primary biliary cholangitis – Is it a novel disease mediator?Xiaochuan Sun, Yihan Cao, Li Wang, Hua Chen, Fengchun Zhang · 2023 · International Journal of Rheumatic Diseases
- Pathophysiologic Basis for Alternative Therapies for CholestasisClaudia Daniela Fuchs, Emina Halilbasic, Michael A Trauner · 2020 · Wiley eBooks
- Can simple non-invasive fibrosis models determine prognostic indicators (fibrosis and treatment response) of primary biliary cholangitis?Süleyman Sayar · 2021 · SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital
- Recurrent primary biliary cholangitis after liver transplantation: A global meta-analysis of epidemiology and risk factorsPedro Robson Costa Passos, Valbert Oliveira Costa Filho, Mariana Macambira Noronha, Yohanna Idsabella Rossi, Isabelle Castro Vitor, Milena Ramos Tomé, Wellgner Fernandes Oliveira Amador, Igor Boechat Silveira, Marina de Assis Bezerra Cavalcanti Leite, Rodrigo Vieira Motta et al. · 2025 · American Journal of Transplantation
- Primary Biliary Cholangitis Pathogenesis: A Pathophysiology-Based Narrative ReviewKlairi Papachristou, Maria Angelara, Konstantinos Manganas, Θεόδωρος Ανδρουτσάκος · 2026 · International Journal of Molecular Sciences
- Clinical characterization of patients with primary biliary cholangitis: A report from multiple Canadian centresEric M. Yoshida, Mark G. Swain, Cynthia D Tsien, Edward Tam, Robert James Bailey, Dusanka Grbic, Hin Hin Ko, Alnoor S. Ramji, Nir Hilzenrat, Magdy Elkhashab et al. · 2022 · Canadian Liver Journal
- Anti-centromere antibody positivity with coexisting idiopathic portal hypertension and primary biliary cholangitis progressing to limited cutaneous systemic sclerosis: a case reportYuya Ando, Suguru Mabuchi, Norikazu Mataki, Satoshi Nakayama, Arata Honda, Mari Kamiya, Shinsuke Yasuda, Hiroaki Takeo, Shigeaki Aono, Masayoshi Hashimoto et al. · 2025 · Journal of Medical Case Reports
- Inborn Errors of Immunity in Adults with Autoimmune Liver DiseasesŞefika Nur Ayar, Elif Soyak Aytekin, Cem Şimşek · 2024 · The Turkish Journal of Gastroenterology
- Adverse events associated with obeticholic acid: a real-world, pharmacovigilance studyChunxia Zhang, Jianguo Wang · 2025 · Expert Opinion on Drug Safety
- New‐onset primary biliary cholangitis in anti‐mitochondrial antibody‐positive patients may be underestimated without liver biopsyZaixing Yang, Y. Liang · 2020 · Journal of Internal Medicine
- Linee guida SIPMeL per la determinazione degli autoanticorpi nella diagnosi delle malattie autoimmuni del fegatoMaria Concetta Sorrentino, a nome del GdS-AI SIPMeL, Teresa Carbone, Luigi Cinquanta, Maria Grazia Alessio, Maria Giaele Infantino, Gaia Deleonardi, Maria T. TREVISAN, Brunetta Porcelli, Lucia Terzuoli et al. · 2024 · La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine
- Treatment of primary biliary cirrhosis with ursodeoxycholic acid combined with traditional Chinese medicineXing Chen, Xiao Ma, Ruilin Wang, Lifu Wang, Jianyu Li, Honghong Liu, Tingting He, Shizhang Wei, Haotian Li, Min Wang et al. · 2020 · Medicine
- Update der S3-Leitlinie „Seltene Lebererkrankungen (LeiSe LebEr) – Autoimmune Lebererkrankungen von der Pädiatrie bis zum Erwachsenenalter“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – Living guidelineMarcial Sebode, Heike Bantel, Ulrich Baumann, Philip Bufler, Münevver Demir, Leona Dold, Verena Keitel, Reinhild Klein, Andreas Emanuel Kremer, Petra Lynen Jansen et al. · 2026 · Zeitschrift für Gastroenterologie
- Prognostic significance of serum tyrosine concentration in patients with primary biliary cholangitis under ursodeoxycholic acid therapyNozomi Amano, Yuji Ikeda, Sho Hayashida, Sho Takahashi, Sho Sato, Ayato Murata, Hironori Tsuzura, Shunsuke Sato, Yuji Shimada, Katsuyori Iijima et al. · 2019 · Hepatology Research
- Comparative characteristics of the clinical and laboratory features of the primary Sjogren’s syndrome associated with anticentromere antibodies and the “classic” subtype of the diseaseB. D. Chaltsev, V. I. Vasiliev, S G Palshina · 2021 · Rheumatology Science and Practice
- Fluctuations of antimitochondrial antibodies and anti-gp210 antibody in a patient with primary biliary cholangitis and Sjögren syndrome with subsequent autoimmune hemolytic anemiaDantong Zhao, Yanmin Liu, Ying Han, Haiping Zhang, Yan Zhao, Huiping Yan · 2020 · Medicine
- Primary Biliary CholangitisNora V. Bergasa · 2021 · Springer eBooks
- Prognostic Significance of Bile Duct Loss in Early‐Stage Primary Biliary Cholangitis: A Long‐Term Observational StudyTaiki Okumura, Takefumi Kimura, Takanobu Iwadare, Shun‐ichi Wakabayashi, Hiroyuki Kobayashi, Yūki Yamashita, Satoru Joshita, Michiharu Komatsu, Naoki Tanaka, Akihiro Matsumoto et al. · 2025 · Hepatology Research
- The Many Faces of Primary Sclerosing Cholangitis: Controversy AboundsBrian J. Wentworth, Rachita Khot, Stephen Hugh Caldwell · 2023 · Digestive Diseases and Sciences
- Gastroesophageal varices in primary biliary cholangitis with anti-centromere antibody positivity: Early onset?Han Shi, Qi Wang, Hui Liu, Bin Xu, Yanmin Liu, Juan Zhao, Lina Sun, Dexi Chen, Chunyang Huang, Rong-Hua Jin · 2024 · Open Life Sciences
- Clinical Performance of the Line Immunoassay and Digital Liquid Chip Method for Detecting Autoimmune Liver Disease AutoantibodiesHeye Lv, Ao Deng, Yijun Chen, Zhenzhen Su · 2024 · Archives of Pathology & Laboratory Medicine
- Pruritus, Fatigue, Osteoporosis and Dyslipoproteinemia in Pbc Patients: A Clinician’s PerspectiveSylvia Dražilová, Tomáš Koky, Marian Macej, Martin Janíčko, Dagmar Simkova, Ariunzaya Tsedendamba, С.Г. Комарова, Peter Jarčuška · 2024 · Gastroenterology Insights
- Diagnostic performance of FibroTest-ActiTest, transient elastography, and the fibrosis-4 index in patients with autoimmune hepatitis using histological referenceValentina Peta, Yu.G. Sandler, Olivier Deckmyn, Oksana Duroselle, E. V. Vinnitskaya, Sergey Khomeriki, Karina K. Noskova, Thierry Poynard · 2025 · World Journal of Hepatology
- Machine learning prediction model for treatment responders in patients with primary biliary cholangitisNaruhiro Kimura, Kazuya Takahashi, Toru Setsu, Shu Goto, Suguru Miida, Nobutaka Takeda, Yuichi Kojima, Yoshihisa Arao, Kazunao Hayashi, Norihiro Sakai et al. · 2023 · JGH Open
- Interactions of Drugs for Liver DiseasesMarina Mudrovčić, Lucija Virović Jukić, Doris Ogresta, Ivica Grgurević · 2024 · Clinical gastroenterology
- Noninvasive elastography-based assessment of liver fibrosis in primary biliary cholangitisXiaohui Ye, Lingling He, Caihong Deng, Junru Yang, Ping Li, Hongshan Wei · 2025 · Annals of Hepatology
- Increased sensitivity of gp210 autoantibody detection using a newly designed gp210 antigenJing Xu, Haoyi Zhang, Chan Wang, Peng Jiang, Chongxu Han, Yaping Dai, Fang Qiu, Yuhua Gong, Yuzhang Jiang, Ping Xu et al. · 2021 · Journal of Immunological Methods
- Pathogenesis and Systemic Treatment of Hepatocellular Carcinoma: Current Status and ProspectsWanting Lei, Kexun Zhou, Ye Lei, Qiu Li, Hong Zhu · 2024 · Molecular Cancer Therapeutics
- Pathophysiology of biochemical signs of primary biliary cholangitisVasiliy Ivanovich Reshetnyak, Igor Veniaminovich Maev · 2023 · Exploration of Digestive Diseases
- Antimitochondrial Antibodies and Primary Biliary Cholangitis in Patients with Polymyalgia Rheumatica/Giant Cell ArteritisCiro Manzo, Maria Maślińska, Alberto Castagna, Elvis Hysa, Alfonso Merante, Marcin Milchert, Tiziana Gravina, Betül Sargın, Maria Natale, Carmen Ruberto et al. · 2021 · Medicina
- Protective effects of Polygonum cuspidatum bioactive constituents against cholestatic liver injury: A mechanistic reviewZengni Zhang, Xiao Yang, Yan Fu, Huilin Wei, Yajuan Chen, Anlin Dai, Xia Zhou, Jun Wan, Wenwen Chen · 2025 · Fitoterapia
- Prevalence of Celiac Disease in Patients With Primary Biliary Cholangitis: A Systematic Review and Meta‐AnalysisFabiana Zingone, Cristina Canova, Anders Forss, Fahim Ebrahimi, Nora Cazzagon, Isabella Rosato, Jonas Filip Ludvigsson · 2025 · Liver International
- High frequency of ABCB4 and ABCB11 gene variants in adult patients with idiopathic chronic or recurrent cholestasisPaulo Lisboa Bittencourt, Vivian Rotman, Liana Codés, Antônio Ricardo Cardia Ferraz de Andrade, Raimundo Araújo Gama, Lívia Geovana Falcão Barbosa Celestino, Raymundo Paraná, Maria Lúcia Gomes Ferraz, Larissa Sampaio de Athayde, Richard J. Thompson et al. · 2025 · Hepatology Communications
- Liver transplant outcomes in primary biliary cholangitis and metabolic dysfunction-associated steatotic liver disease overlapLeandro Sierra, Shahana Prakash, Jamak Modaresi Esfeh, Omar T. Sims, Dian Jung Chiang · 2026 · Annals of Hepatology
- Secondary Treatment of Primary Biliary Cholangitis: Early Prediction of Inadequate Response to Ursodeoxycholic Acid in Patients with PBCB. Liu, K. Qureshi · 2022 · Digestive Diseases and Sciences
- Tumor necrosis factor alpha-induced protein 3: A key biomarker for response to ursodeoxycholic acid in primary biliary cholangitisBo Zang, Jiaxiu Li, Qi-Xuan Liu, Yuan Yao, Hua Li, Yan Wang, Jigang Wang, Yifei Yang, Ruiwen Liang, Xin-Ran Xin et al. · 2025 · World Journal of Hepatology
- Seladelpar in patients with primary biliary cholangitis and compensated cirrhosis: Efficacy and safety from RESPONSE and ASSURE studiesStuart C. Gordon, Alejandra Villamil, Ira M. Jacobson, Eric Lawitz, Ziad H Younes, Marina G. Silveira, Christopher L. Bowlus, Joost P.H. Drenth, John Moore Vierling, Ulrike Morgera et al. · 2026 · Hepatology Communications
- Primary Biliary Cholangitis in 2025: A New FrontierHannah R. Klatzkow, Indira Bhavsar‐Burke, Meredith M. Pearson, Brian J. Wentworth · 2025 · The American Journal of Gastroenterology
- Liver Fibrosis: Molecular Pathogenesis and Therapeutic InterventionsJiaorong Qu, Wenqing Qin, Minghang Dong, Zhi Ma, Si Li, Liu R, Ranyun Chen, C H Li, X Li · 2026 · MedComm
- Novel preclinical developments of the primary sclerosing cholangitis treatment landscapeAalam Sohal, Kris V. Kowdley · 2024 · Expert Opinion on Investigational Drugs
- The relationship between CXCR6+CD8+T cells and clinicopathological parameters in patients with primary biliary cholangitisHuilian Shi, Xiangtao Xu, Shuangshuang Wang, Qinlei Chen, Fan Zhang, Haiyan Guo, Weiting Lu, Fei Qiao · 2024 · Hepatology International
- EASL-AASLD Delphi consensus statement on surrogate endpoints and real-world evidence in primary biliary cholangitisCynthia Levy, Ana Lleo, Adrielly Martins, Miki Scaravaglio, Christopher L. Bowlus, Marco Carbone, Christophe Corpechot, Cláudia Alves Couto, Bettina E. Hansen, Gideon Morris Hirschfield et al. · 2026 · Journal of Hepatology
- Seladelpar Improves Cholestasis and Pruritus in Obeticholic Acid and Fibrate-Experienced Patients With Primary Biliary CholangitisGordon Sv, Sarah Proehl, Daniel Pratt · 2026 · Clinical Gastroenterology and Hepatology
- Primary biliary cholangitis with inflammation involving zone 3 of the liver has a poor response to ursodeoxycholic acid treatment: a retrospective cohort studyHuanqiao Zhong, Mengyao Zheng, Chunmei Zhao, Qun Wei, Zhiyan Ou, Tianyun Wang, Ning Li, Zhitian Shi, Sidi Li, Yao Yao et al. · 2026 · BMC Gastroenterology
- Autotaxin: A Potential biomarker for primary biliary cholangitisYifei Yang, Bingqian Liu, Bo Zang, Qixuan Liu, Chenyang Zhao, Yuan Yao, Bin Liu · 2023 · Heliyon
- Long‐Term Use of Fenofibrate as Second‐Line Therapy in Primary Biliary Cholangitis: A Retrospective StudyMariko Maxwell, Yanhong Deng, Bonnie Chen, Marina G. Silveira, James Lorenzen Boyer, David N. Assis · 2026 · Alimentary Pharmacology & Therapeutics
- Bile Duct DiseasesYoh Zen, Stefan G. Hübscher, Yasuni Nakanuma · 2023 · Elsevier eBooks
- Association of sarcopenia assessed by CT/MRI with treatment response and clinical outcomes in noncirrhotic primary biliary cholangitis patientsLeyu Zhou, Bo Li, Zhetao Wang, Xiaoyan Ao, Xianglin Wang, Yanyi Zheng, Yazhou He, Xiaoli Fan, Li Yang · 2025 · European Journal of Radiology
- Primary Biliary CholangitisAtsushi Tanaka, Patrick S.C. Leung, Christopher L. Bowlus, Merrill Eric Gershwin · 2020 · Springer eBooks
- Gender-specific development of experimental autoimmune cholangitis induced by double-stranded RNAShunin Someya, Akira Uchiyama, Kumiko Arai, Kazuyoshi Kon, Shunhei Yamashina, Sumio Watanabe, Kenichi Ikejima · 2021 · Biochemical and Biophysical Research Communications
- Acute coronary syndrome after liver transplantation in a young primary biliary cholangitis recipient with dyslipidemia: a case reportSiyuan Yao, Akiho Iwashita, Shintaro Yagi · 2022 · Surgical Case Reports
- Antimitochondrial Antibody-Negative Primary Biliary Cholangitis: A Retrospective DiagnosisRami Al-Handola, Justine M. Chinnappan, Murtaza Shabbir Hussain, Abdullahi Elsheikh Mahgoub, Ghassan I. Bachuwa · 2023 · Cureus
- Pharmacovigilance of obeticholic acid: An analysis of the Food and Drug Administration Adverse Event Reporting System databaseQining He, Mengting Jiang, Yuchen Wang, Tao Zheng · 2025 · British Journal of Clinical Pharmacology
- MicroRNA-126-3p as a predictive biomarker for patients with primary biliary cholangitis refractory to ursodeoxycholic acidShi-Da Pan, Chu-Yue Xiong, Ying-Juan Shen, Jiahe Tian, Yilin Wang, Jia‐Ning Wang, Siyu Wang, Fengyi Li, Lifeng Wang, Qin Qiu et al. · 2025 · World Journal of Gastroenterology
- Colangitis biliar primaria: caracterización de una cohorte retrospectivaEdgar Fernando Ayala-Sierra, Octavio Germán Muñoz Maya, Felipe Guerrero-Pérez, Manuela Cardona-Jaramillo · 2022 · Hepatología
- Dysregulation of Farnesoid X Receptor on Neutrophil Homeostasis Exacerbates Intestinal Inflammation via the mTORC1‐Glycolysis Signaling PathwayDengfeng Kang, Ai Q. Li, Xiangqi Xie, Han Liu, Liang Chen, Zhongsheng Feng, Xiang Gao, Han Gao, Xiaohan Wu, Huiying Lu et al. · 2026 · MedComm
- The Role of Bezafibrate, a Peroxisome Proliferator‐Activated Receptor Alpha Agonist, in Patients With Primary Biliary CholangitisDaniel Stephan Pratt · 2019 · Hepatology
- Application Value of Novel Inflammatory Indicators in Response to Ursodeoxycholic Acid Therapy in Patients with Primary Biliary CholangitisSiqi Liu, Yongli Pang, Xiaoxi Wang, Ruihang Lin, Siqing Tunala · 2025 · International Journal of General Medicine
- Autoantibodies in the diagnostics, prognostics and follow-up of primary biliary cholangitisPéter Antal‐Szalmás, Dóra Bencze, Sarolta Demeter, Krisztina Pénzes, Lilla Szabó, Beáta Tóth, Róza Földesi, Mária Papp, Gábor Nagy · 2026 · Journal of Translational Autoimmunity
- Primary Biliary Cholangitis2017 · Elsevier eBooks
- Real-world performance of transient elastography in assessing advanced fibrosis in Chinese patients with primary biliary cholangitisJialiang Chen, Yixin Hou, Yao Liu, Yuyong Jiang, Xianbo Wang · 2025 · World Journal of Gastroenterology
- Registry of patients with autoimmune liver diseases in St. Petersburg: clinical and epidemiological dataИгорь Геннадьевич Бакулин, Svetlana A. Burlakova, Сказываева Екатерина Васильевна, Maria I. Skalinskaya · 2024 · HERALD of North-Western State Medical University named after I I Mechnikov
- An observational study of the causes of an isolated elevated alkaline phosphatase level of unclear etiologyWilliam Stephen Jones, Don C. Rockey · 2024 · The American Journal of the Medical Sciences
- Serum microRNA 143 and 223 Gene Expression Profiles as Potential Biomarkers in Individuals with Hepatitis and COVID-19Lucas Lima da Silva, Luciane Almeida Amado Leon, Otacílio C. Moreira · 2024 · Viruses
- Clinical aspects and prognosis of patients with inflammatory bowel disease associated with autoimmune liver diseasesHenrique Carvalho Rocha, Eduardo García Vilela · 2022 · Gastroenterología y Hepatología (English Edition)
- Leukemia inhibitory factor promotes human cholangiopathies, and its inhibition improves cholestasis in Abcb4 −/− miceCristina Di Giorgio, Ginevra Urbani, Carmen Massa, Silvia Marchianò, Michele Biagioli, Martina Bordoni, Ginevra Lachi, Benedetta Sensini, Rachele DEL SORDO, Francesca Paniconi et al. · 2025 · Hepatology Communications